Mark DuerkopFeb 9, 20224 minIndustry 4.0: Where are we, and how to accelerate the transition?Strategies to faster implement pharma 4.0 concepts in biopharmaceutical industry using advanced data storing platform and hybrid modeling
Mark DuerkopJul 28, 20212 minAntleron and Novasign to join forces in ATMP ModelingAntleron and Novasign announce their collaboration in developing advanced process modeling strategies for ATMP manufacturing.
Benjamin BayerApr 3, 20203 minCOVID-19: An example of why we need robust and fast process developmentThe current worldwide situation regarding the COVID-19 pandemic has shown all of us how vulnerable our daily life can be. In the case of...
Mark DuerkopMar 18, 20202 minCOVID-19, home office and a new toolbox releaseTo Speedup Bioprocess Development Novasign just released a new version of a powerful hybrid modeling toolbox during home office and COVID19
Maximilian KripplOct 18, 20192 minThe Hybrid Modeling Summer School 2019From the 25th to the 27th of September, Novasign co-hosted the 4th hybrid modeling summer school in Lisbon, Portugal. After a very...
Mark DuerkopAug 27, 20192 minBeyond static process descriptionsHave you ever used DoE tools to describe your upstream bioprocess? If so you most definitely have missed the essentials: the dynamics!
Mark DuerkopMar 27, 20192 minBioprocessing Europe LisbonLast week we have been to Bioprocessing Europe in Lisbon. The conference was organized in a brought manner, offering both, an up- and...
Mark DuerkopNov 7, 20183 minReducing the costs of biopharmaceuticals: a bioprocess development approach In 2018 the generated revenue by biopharmaceuticals is estimated to be approximately 200 b$! Although this is an incredibly high number,...
Mark DuerkopAug 8, 20181 minBest talk @10th ÖGMBT Annual MeetingFrom the 17th to the 20th of September, the 10th ÖGMBT Annual Meeting took place in Vienna. Over 450 participants including employees...